PHARMA

Quarterly rpt on consolidated results for the financial period ended 30 Jun 2020

PHARMANIAGA BERHAD

Financial Year End 31 Dec 2020
Quarter 2 Qtr
Quarterly report for the financial period ended 30 Jun 2020
The figures have not been audited

Attachments

Q2 2020 Bursa announcement.pdf
518.5 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30 Jun 2020

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Jun 2020
30 Jun 2019
30 Jun 2020
30 Jun 2019
$$'000
$$'000
$$'000
$$'000
1 Revenue
645,763
601,890
1,465,684
1,387,998
2 Profit/(loss) before tax
14,326
12,481
45,206
42,724
3 Profit/(loss) for the period
9,607
9,262
32,022
28,910
4 Profit/(loss) attributable to ordinary equity holders of the parent
9,979
9,281
32,378
28,898
5 Basic earnings/(loss) per share (Subunit)
3.82
3.56
12.39
11.09
6 Proposed/Declared dividend per share (Subunit)
2.50
2.50
8.50
8.50


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
1.3700
1.2900

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 19 Aug 2020
Category Financial Results
Reference Number FRA-18082020-00043